Natera

US · NTRA #387 by market cap Listed 2015

395.56 -5.09 -1.27%

Live - 5344 symbols - heartbeat 26s ago · 2026-10-08 07:00

Pre-market 392.49 -0.78%

After-hours 397.00 +0.36%

Overnight 394.41 -0.29%

Market cap: 57.02B
P/E (TTM): -293.01
P/B: 31.30
EPS: -1.52
Div yield: 0.00%
52W pos: 84%

Reader sentiment Are you bullish or bearish on NTRA?

Anonymous reader poll. Unscientific, not investment advice.

About Natera

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.

Founded: 2003
CEO: Mr. Steven Leonard Chapman
Employees: 6,140
Headquarters: Austin, Texas, United States of America
Fiscal year end: 12-31
Website: natera.com

Company profile

Exchange: US
Symbol: NTRA
Market-cap rank: #387
Listing date: 2015-07-02
Market cap: 57.02B
Float cap: 55.43B
Shares out: 144.14M
Float shares: 140.12M

Sectors & themes

Diagnostics & Research ARK Portfolio Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 07:00:13 · For reference only, not investment advice and not tailored to your situation.